Actively Recruiting
Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome
Led by First Affiliated Hospital of Fujian Medical University · Updated on 2026-04-23
8000
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a single-center observational registry study aiming to establish a structured clinical and multimodal imaging database for cardiovascular-kidney-metabolic (CKM) populations and to support lifecycle follow-up and outcome management. Adult patients aged 18-80 years with cardiovascular, kidney, and/or metabolic diseases or key data for CKM phenotyping will be enrolled at the First Affiliated Hospital of Fujian Medical University. The study integrates retrospective data entry and prospective follow-up, including clinical records, laboratory tests, medications, electrocardiography, echocardiography, vascular function assessment, carotid and abdominal ultrasound, bone density, coronary CTA and post-processing data. The primary outcome is the first occurrence of a cardiorenal composite endpoint. Participants will be followed for up to 5 years through active annual follow-up and passive monthly data updates to support risk stratification, real-world evidence generation, and CKM management pathway optimization.
CONDITIONS
Official Title
Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Inpatient record available at the First Affiliated Hospital of Fujian Medical University with retrievable identifiers for data linkage
- Cardiovascular disease, kidney disease, metabolic disease, or key examination/laboratory information supporting CKM phenotyping
- Willingness to participate and provision of written informed consent
- Ability to complete baseline assessment and follow-up
- Full civil capacity and ability to understand study information
You will not qualify if you...
- Refusal to provide written informed consent
- Severe psychiatric disease or cognitive impairment precluding participation
- End-stage disease with expected survival less than 1 year
- Long-term absence more than 6 months preventing reliable follow-up
- Participation in another clinical study that may interfere with endpoint adjudication
- Missing key fields preventing linkage of examinations, imaging, and outcomes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China, 350011
Actively Recruiting
Research Team
D
Dajun Chai
CONTACT
H
Hailin Zhang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here